Browse All Treatments

Showing 1856 records.


Page 81 of 186 1 79 80 81 82 83 186
Order by:
SurvivalPatientsToxicityTreatmentHospitalCountryDate
80113.4 monthsRecurrent or progressing GBMBiologic therapyDrexel University College of MedicineUnited StatesJan 2002
Treatment Details: Patients: This Phase II study involved 180 patients with high grade glioma. The patient population consisted of 118 patients with glioblastoma multiforme, 55 with anaplastic astro... read more
80213.4 monthsHormone refractory prostate cancer4ChemotherapyGeorges Pompidou European HospitalFranceMay 2005
Treatment Details: Patients: This Phase II study enrolled 130 men, who were randomized into three groups. Group C had 42 men (median age 70) with hormonal-resistant prostate cancer. One patient had... read more
80313.4 monthsNSCLC5Chemotherapy, Biologic therapyRobert H. Lurie Comprehensive Cancer CenterUnited StatesDec 2013
Treatment Details: Patients: This phase 3 study involved nonsquamous non-small cell lung cancer patients who were divided into two separate treatment groups. Group A consisted of 472 patients with a... read more
80413.4 monthsGBM5Chemotherapy, RadiationUAB Department of Neurology United StatesMay 2015
Treatment Details: Patients: This phase 2 study involved unmethylated MGMT gene promoter glioblastoma patients who were divided into two separate treatment groups. Group A had 88 patients with a med... read more
80513.4 monthsMetastatic, Castration-Resistant Prostate Cancer4ChemotherapyThe Royal Melbourne HospitalAustraliaJun 2015
Treatment Details: Patients: This study involved 20 elderly metastatic castration-resistant prostate cancer patients with a median age of 83 years (range: 80-93). Treatment: Patients received ch... read more
80613.4 monthsNewly diagnosed GBM3ChemotherapyRoyal Melbourne HospitalAustraliaNov 2011
Treatment Details: Patients: This phase II study involved 40 newly diagnosed glioblastoma multiforme (GBM) patients who had previously received radiation therapy. The median patient 53 years and 73... read more
80713.4 monthsHER2-negative advanced breast cancer 5Chemotherapy, Biologic therapyMemorial Sloan-Kettering Cancer CenterUnited StatesMay 2013
Treatment Details: Patients: This phase 2 study involved female HER2-negative advanced breast cancer patients previously treated with bevacizumab who were divided into two separate treatment groups ... read more
80813.3 monthsMetastatic, castration-resistant prostate cancer5Chemotherapy, Biologic therapyKantonsspital Graub€undenSwitzerlandNov 2012
Treatment Details: Patients: This phase 2 study involved previously treated metastatic castration-resistant prostate cancer patients with a median age of 68 years. Treatment: Patients were treat... read more
80913.3 monthsAdvanced or metastatic non-squamous NSCLC5Chemotherapy, Biologic therapyAir Force HospitalGreeceMar 2013
Treatment Details: Patients: This phase 2 study involved 48 advanced or metastatic non-squamous non-small-cell lung cancer patients who had not received prior chemotherapy. The median patient age w... read more
81013.3 monthsAdvanced NSCLC5Biologic therapyDana-Farber Cancer InstituteUnited StatesNov 2013
Treatment Details: Patients: This phase 3 study involved advanced non-small-cell lung cancer patients who were separated into two different treatment groups. Group A consisted of 373 patients with ... read more
Page 81 of 186 1 79 80 81 82 83 186